Online experts meeting on Discovery of Novel Microbial Strains & the Impact of the Nagoya protocol | November 24, 2020
Home » Experts meetings » Online experts meeting on Discovery of Novel Microbial Strains & the Impact of the Nagoya protocol | November 24, 2020
Register now for our next online experts meeting on “Discovery of Novel Microbial Strains and the Impact of the Nagoya protocol“. In this meeting experts and stakeholders from both academia and industry will meet, share and discuss challenges and opportunities. The meeting will be aired live on Tuesday November 24, 2020.
Experts from the Centre for Genetic Resources, DSM Nutritional Products, WUR, SINTEF and BaseClear will share their knowledge and insights on how the Nagoya protocol influences the discovery and industrial use of microbial strains. In addition the reclassification of the genus Lactobacillus is discussed, including the impact this has on commercial use and regulatory aspects of these strains.
Dr. Derek Butler | Commercial Director, BaseClear
Dr. Radhika Bongoni | Head of Business Development, BaseClear
Session 1: Discovery of novel microbial strains Session starts at 10.30 Central European Time
Unlock: An open large-scale infrastructure for exploring new horizons for research on microbial communities
Dr. Peter Schaap | Associate Professor, WUR
Expanding the (meta)genomics toolbox for novel enzyme and bioactive compound discovery and production
Dr. Alexander Wentzel | Senior researcher, SINTEF
The importance of culturomics for unraveling microbial life in extreme environments
Dr. Aleksandrina Patyshakuliyeva | Product Manager – BaseClear
Session 2: The Nagoya protocol and re-classification of strains Start at 14.30 Central European Time
The Nagoya protocol: what you need to know
Dr. Martin Brink | Policy Advisor, Centre for Genetic Resources
Industry perspective on the Nagoya protocol
Dr. Markus Wyss | Strain Director, Global Regulatory Affairs & Quality Management, DSM Nutritional Products
The impact of re-classification of microbial strains
Dr. Adalberto Costessi | Product Manager Genomics & Regulatory Affairs, BaseClear
If you are interested in this topic, send us a message.
Dr. Derek Butler is BaseClear's CEO. He has served BaseClear for the last 15 years in a number of leadership positions. He is a microbiologist and a graduate of University College Cork and TIAS Business School. Dr. Butler has more than 20 years of biotech experience and has held a number of commercial and scientific roles within BaseClear. He is also the co-founder of Leiden-based MyMicroZoo, a company that offers direct-to-consumer microbiome testing.